Crossmark

A review of genetic and epigenetic biomarkers involved in the occurrence of atypical hemolytic uremic syndrome and its therapeutic strategies

Published Online: 2026-05-14

Published Print: 2026-12

Authors

Tohidi, Mohamadreza

Mohammadi, Mahan
License Information

Text and Data Mining valid from 2026-05-14

Version of Record valid from 2026-05-14
More Information

Article History

Received: 28 November 2025

Accepted: 1 May 2026

First Online: 14 May 2026

Declarations

:

: The authors declare no competing interests.

: This research was approved by research deputy of Kermanshah University of Medical Sciences, Kermanshah, Iran (Ethics approval ID: IR.KUMS.REC.1404.214).

: No individual participants included in the research.

Document is current